2019-IgG IgM COVID-19 Test Kit ( Colloidal Gold - Based ) Place Of Origin

Intended Use

This product was used to detect 2019 nCoV IgM / IgG antibodies in human serum, plasma, or whole blood.It was only used as a supplementary test index for suspected cases with negative nCoV nucleic acid test results in 2019, or in combination with nucleic acid test to diagnose suspected cases.
This product is used for adjuvant diagnosis and emergency storage in patients with COVID-19 infection

Test Method

---

1. Prepare for the experiment
Reagents and samples were removed, and all reagents and samples were recovered to room temperature.
2. Experimental procedures
(1) Open the aluminum foil bag.Remove the test paper and place it horizontally.
(2) Add 10 L of the samples to the injection hole of the test note, and add 2 drops of (~60 L) of the sample buffer.
(3) Response at room temperature.Test results were read after 10 – 15 minutes.The results were invalid after 20 minutes.
(4) Simple operating procedure
Open the package, remove the test paper and place it horizontally
↓
The 10 L samples were added to the injection wells of the test paper
↓
Add 2 drops (~60 L) of the sample buffer to the sample well
↓
Reaction occurred for 10 – 15 min at room temperature
Read the results with the naked eye.

Interpretation of test results

---

Negative,Positive,Invalid

Test Results Figure:
(1) Invalid result: if there is no visible red line or test-only
Cable (line T line), but no quality control line (line C), the result is
Invalid, and needs to be re-tested.
(2) Negative result: if only the red control line
(Line C), indicating the absence of antibodies or antibodies in the sample
Antibodies were placed below the test level.
(3) Positive result: if there are two red lines (one red mass
Control line and a red test line) or three red lines (one red
Quality control line and two red test lines) and were positive.

Company profile

---

Zhongxiu Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company always adheres to the core concept of "fast and accurate, not living up to life", is committed to providing excellent products and services for the society, and contributes to the cause of human health.

Zhongxiu Qualifications

---

DOC

White List

---

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.